CJC-1295 research guide for Kaesong. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
Kaesong represents a varied regulatory and logistical environment for research peptide access — researchers in various locations across Kaesong may encounter varying import handling. What varies is the practical path to finding vendors who have shipped reliably to Kaesong and maintain strong quality documentation — community research drawn from Kaesong researcher threads provides the most useful vendor intelligence. Community forums that include Kaesong-based members are a valuable reference of current vendor experience — the research community's informal databases of vendor shipping experience by destination are particularly valuable in this geographic context. The sections below provide the quality evaluation tools plus Kaesong-specific context for CJC-1295 researchers throughout Kaesong.
CJC-1295: Research & Evidence
The oral bioavailability of MK-677 (Ibutamoren) distinguishes it from other compounds in the GHS class and has research design implications for Kaesong researchers. As an oral GHS, MK-677 avoids the technical requirements of injectable administration, making it more accessible for longer-term studies in non-specialized settings. Its half-life of approximately 24 hours produces a sustained GH elevation pattern, different from the acute pulsatile stimulation of injectable GHRPs. Kaesong researchers selecting between CJC-1295 options should consider whether acute pulsatile GH stimulation or sustained GH elevation is more relevant to their specific research question.
Kaesong researchers sourcing CJC-1295 should factor in typical shipping timelines: international peptide shipments to Kaesong typically take 5-15 business days depending on supplier geography and chosen delivery option. Quality markers remain the same regardless of destination: batch-matched COA with HPLC purity ≥98%, mass spec identity confirmation, and bacterial endotoxin results — all verifiable before purchase. Express shipping options from most major vendors reduce delivery timelines to 3-7 days — customs delays are the primary source of variability, typically adding 2-5 business days for standard processing. The community research step is often underweighted by new buyers — it is the most valuable step before any CJC-1295 purchase for Kaesong researchers.
Safe Research Practices for CJC-1295
CJC-1295 is a research compound not licensed for human application — storage: lyophilised at −20 degrees Celsius, reconstituted solution stored at 2-8°C and used within 30 days with bacteriostatic water. Vendor-provided endotoxin testing is a mandatory requirement for injectable research use — verify this is present in the batch-matched COA before any in-vivo protocol. These three steps define responsible CJC-1295 research in Kaesong and everywhere: quality sourcing from a vendor with complete COA data, sterile handling with correct storage, and written documentation of all research procedures.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
